- NEWS AND VIEWS
Engineered T cells to treat lupus arrive on the scene
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 611, 456-458 (2022)
doi: https://doi.org/10.1038/d41586-022-03563-1
References
Mackensen, A. et al. Nature Med. 28, 2124–2132 (2022).
Tsokos, G. C. Nature Immunol. 21, 605–614 (2020).
Kaul, A. et al. Nature Rev. Dis. Primers 2, 16039 (2016).
Finck, A. V., Blanchard, T., Roselle, C. P., Golinelli, G. & June, C. H. Nature Med. 28, 678–689 (2022).
Kansal, R. et al. Sci. Transl. Med. 11, eaav1648 (2019).
Muñoz-Rojas, A. R. & Mathis, D. Nature Rev. Immunol. 21, 597–611 (2021).
Chen, P.-M. et al. Sci. Adv. 8, eabo4271 (2022).
Fujisaki, J. et al. Nature 474, 216–219 (2011).
Zhang, W. et al. Stem Cell Rev. Rep. 17, 2120–2123 (2021).
Ruff, W. E., Greiling, T. M. & Kriegel, M. A. Nature Rev. Microbiol. 18, 521–538 (2020).
Smith, M. et al. Nature Med. 28, 713–723 (2022).
Jing, R. et al. Cell Stem Cell 29, 1181–1196 (2022).
Sharabi, A. et al. Nature Rev. Drug Discov. 17, 823–844 (2018).
Competing Interests
The author declares no competing interests.